Pablo Arija

Pablo Arija

Auto-generated profile, based on publicly available information

Pablo Arija

Patient-Centered Outcomes, OPEN Health, Rotterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2022 in Journal of Tissue Viability
Verified
Journal Article
Closed access
VVVladica M. Veličković
Vladica M. Veličković
PPPablo Arija Prieto
Pablo Arija Prieto
MKMilica Krga
Milica Krga
AJAna Maria Jorge
Ana Maria Jorge

16 May 2024 in Health Policy
Verified
Journal Article
Open access
PPPablo Arija Prieto
Pablo Arija Prieto
MAMarcello Antonini
Marcello Antonini
MAMehdi Ammi
Mehdi Ammi
MGMesfin Genie
Mesfin Genie
FPFrancesco Paolucci
Francesco Paolucci
The COVID-19 pandemic is one of the most significant public health crises in modern history, with considerable impacts on the policy frameworks of national governments. In response to the pandemic, non-pharmaceutical interventions (NPIs) and mass vaccination campaigns have been employed to protect vulnerable groups. Through the lens of Political Budget Cycle (PBC) theory, this study explores the interplay between incumbent electoral concerns and political dynamics in influencing the implementation of NPIs and vaccination rollout within the administrative regions of Italy and Spain during the period spanning June 2020 to July 2021. The results reveal that incumbents up for the next scheduled election are 5.8 % more likely to increase the stringency of containment measures than those that face a term limit. The findings also demonstrate that the seats of the incumbent and coalition parties in parliament and the number of parties in the coalition have a negative effect on both the efficiency of the vaccination rollout and the stringency of NPIs. Additionally, the competitiveness of the election emerges as an important predictor of the strictness of NPIs. Therefore, our results suggest that incumbents may strategically manipulate COVID-19 policy measures to optimize electoral outcomes. The study underscores the substantive influence of political incentives, competitive electoral environments, and government coalitions on policy formulation during health emergencies.

2 April 2026 in Neurology and Therapy
Verified
Journal Article
Open access
PDF file
PAPablo Arija
Pablo Arija
JDJosefa Domingos
Josefa Domingos
IMIrene A Malaty
Irene A Malaty
RPRajesh Pahwa
Rajesh Pahwa
Kallol (K) Chaudhuri also Ray-ChaudhuriKallol (K) Chaudhuri also Ray-Chaudhuri
Kallol (K) Chaudhuri also Ray-Chaudhuri
MBMarco Boeri
Marco Boeri
Introduction Treatments for advanced Parkinson’s disease (aPD) are differentiated by efficacy, safety, and modality-related characteristics. As the disease progresses and motor fluctuations worsen, many patients require more frequent dosing or consideration of device-aided therapies, including subcutaneous infusions, intestinal gel delivery systems, or deep brain stimulation. Assessing treatment preferences is valuable to ensure people with aPD (PwP) and care partners (CPs) are satisfied with a treatment’s impact on both motor function and quality of life, potentially increasing adherence and effectiveness. Methods A total of 304 participants (223 PwP, 81 CPs) from the USA, UK, and Germany were included in the study. A discrete choice experiment (DCE) was used to elicit preferences over treatment characteristics. In the DCE, respondents were presented with a series of choice tasks, each consisting of two hypothetical treatments described by varying levels of seven attributes: daily hours of ON time without troublesome dyskinesia (ONwoTD), frequency of early morning OFF time (EMO), risk of mild-to-moderate skin reactions, risk of severe side effects requiring hospitalization, route of administration (ROA), frequency of pill regimen, and frequency of device maintenance. Analyses with a random parameter logit model were used to estimate attribute conditional relative importance (CRI) and explore how people would trade off across attributes. Results The average PwP age was 65.7 years (SD 8.6), time since diagnosis was 10.0 years (SD 4.4), and self-reported OFF time was 4.0 h/day (SD 2.4). Within the survey design, ROA emerged as the most important attribute (CRI 35.3), followed by hours of ONwoTD (CRI 26.4). All other attributes were of similar importance. Nonsurgical treatments were strongly preferred, with oral pills being the most preferred, followed by infusion device without surgery (subcutaneous infusion). Conclusions PwP prioritized efficacy (ONwoTD) and ROA when considering treatment options. Understanding these preferences may enhance informed and meaningful decision-making between healthcare providers and PwP.

1 January 2023 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
PPPablo Arija Prieto
Pablo Arija Prieto
MAMarcello Antonini
Marcello Antonini
MAMehdi Ammi
Mehdi Ammi
MGMesfin G Genie
Mesfin G Genie
FPFrancesco Paolucci
Francesco Paolucci
The COVID-19 outbreak is one of the most significant public health crises in modern history, with considerable effects on the agendas of governments. Non-pharmaceutical interventions and vaccination campaigns have been designed first and foremost to protect vulnerable groups. However, political considerations of governments matter for policy design. In this study, we follow Political Budget Cycle (PBC) theory to explore whether incumbent electoral concerns and political-related factors influence regional-level adoption of stricter containment measures and the efficiency of the vaccine rollout in the Italian and Spanish regions from June 2020 to July 2021. The results reveal that incumbents up for the next near election are 5.8% more likely to increase the stringency of containment measures than those that face a term limit. The findings also demonstrate that the seats of the incumbent and coalition parties in the parliament and the number of parties in the coalition have a negative effect on both the pace of the vaccination and the stringency of interventions. In addition, the competitiveness of the election is an important determinant of the strictness of the mitigation policies. Therefore, our results suggest that incumbents manipulate COVID-19 policy responses to attract a higher vote share. Political incentives, competition and government coalitions thus have implications for policy making in periods of health emergencies.

14 April 2026 in Journal of Patient-Reported Outcomes
Verified
Journal Article
Open access
PDF file
JDJosefa Domingos
Josefa Domingos
PAPablo Arija
Pablo Arija
IMIrene A Malaty
Irene A Malaty
RPRajesh Pahwa
Rajesh Pahwa
Kallol (K) Chaudhuri also Ray-ChaudhuriKallol (K) Chaudhuri also Ray-Chaudhuri
Kallol (K) Chaudhuri also Ray-Chaudhuri
HPHannah Penton
Hannah Penton
Background: Parkinson’s disease (PD) is characterized by motor and non-motor symptoms that fluctuate as oral medication wears off, causing periods when symptoms return (“OFF” time) and periods of control (“ON” time). These fluctuations often occur at night and early morning. Sleep disturbance (SD) and early-morning OFF time (EMO) have been shown to decrease health-related quality of life (HRQoL) in people with PD (PwP). However, limited evidence exists on how these symptoms impact health state utility values (HSUVs) used in economic modeling. This study aimed to estimate the burden and disutility of SD and EMO in PwP through vignettes valued using the EQ-5D-5 L. Methodology: An online survey was completed by adults (≥ 30 years) with self-reported PD diagnosis for ≥ 5 years and ≥ 2 h/day of OFF time, on oral PD medications, and residing in the US or UK. The survey included EQ-5D-5 L and EQ-VAS assessments for 4 vignettes—No SD or EMO, SD (without EMO), EMO (without SD), and Both SD and EMO—plus questions exploring the burden of SD and EMO. EQ-5D-5 L responses were converted into US utility values to estimate HSUVs and the disutility of SD and EMO. Results: Seventy-five individuals completed the survey; 52.00% were male, and 78.66% resided in the US. The average age was 64.32 years, with a mean time since diagnosis of 9.82 years and an average OFF time of 3.91 h/day. In the previous week, 96.00% and 98.67% of respondents reported experiencing SD and EMO, respectively. The presence of either SD (HSUV: 0.796) or EMO (HSUV: 0.701) alone resulted in lower EQ-5D-5 L utilities, with the presence of both valued least (HSUV: 0.528), compared with when both SD and EMO were absent (HSUV: 0.911). EQ-VAS scores ranged from 81.01 for no symptoms to 48.41 for both. Conclusions: SD and EMO impose a significant burden on PwP and decrease HSUVs. As SD and EMO were associated with significant disutility, they should be incorporated into economic models to comprehensively assess PD treatment benefits. Raising awareness among PwP and healthcare providers and prioritizing treatments that minimize SD and EMO can reduce their burden and improve HRQoL for PwP.

29 August 2026 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
PAPablo Arija
Pablo Arija
NDNicholas Durno
Nicholas Durno
JWJie Wang
Jie Wang
PKPhillip Kittel
Phillip Kittel
PCPaco Cerletti
Paco Cerletti
EDEvan W. Davies
Evan W. Davies
Purpose To develop and validate mapping algorithms that estimate EQ-5D health state utility values (HSUVs) from two diabetes-specific patient-reported outcome measures, the Problem Areas in Diabetes (PAID) and Diabetes Distress Scale (DDS), to support economic evaluations when EQ-5D data are unavailable. Methods Data from 662 adults with diabetes in Germany included PAID-20, DDS-17, and EQ-5D-5L responses. Direct mapping models predicted EQ-5D utilities using Tobit and censored least absolute deviation (CLAD) regressions, while indirect mapping models used proportional and partial proportional odds regressions to predict EQ-5D dimensions. Six model specifications were tested, incorporating PAID and DDS items with covariates (age, sex, diabetes type), with selection of predictors guided by item correlations and backward stepwise procedure to retain statistically relevant variables. Model performance was assessed using a selection of performance metrics including root mean square error (RMSE) and mean absolute error (MAE). Internal validation of the models employed 10-fold cross-validation. Results The strongest-performing direct mapping models consisted of a model with a selection of PAID-20 items and covariates (Tobit regression; RMSE: 0.159; MAE: 0.117) and a model that incorporated PAID-20, DDS-17, and covariates (CLAD regression; RMSE: 0.146; MAE: 0.09), and a model based on DDS-17 items and covariates (Tobit regression; RMSE: 0.164; MAE: 0.121). Indirect mapping models demonstrated higher prediction errors overall (RMSE: 0.187–0.21; MAE: 0.124–0.141) than their counterparts. Conclusions We present novel algorithms that enable estimation of EQ-5D utilities from PAID and DDS scores, facilitating economic evaluation in diabetes. Preferred models demonstrated predictive accuracy comparable to published mapping studies.